CDKN2A and T-cell acute lymphoblastic leukemia: Similarly, β-arrestin1 emerges as a tumor suppressor in T cell Acute Lymphoblastic Leukemia (TALL), inducing senescence via the RAS-p16-pRb-E2F1 pathway and improving chemotherapy response [282].